Charlton-Menys V - Search Results

1

Apolipoprotein B100 is a better treatment target than calculated LDL and non-HDL cholesterol in statin-treated patients.

Soran H, France MW, Kwok S, Dissanayake S, Charlton-Menys V, Younis NN, Durrington PN. Soran H, et al. Among authors: charlton menys v. Ann Clin Biochem. 2011 Nov;48(Pt 6):566-71. doi: 10.1258/acb.2011.010277. Epub 2011 Oct 17. Ann Clin Biochem. 2011. PMID: 22006975

2

Targets of statin therapy: LDL cholesterol, non-HDL cholesterol, and apolipoprotein B in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS).

Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, Livingstone SJ, Neil HA, Newman CB, Szarek M, DeMicco DA, Durrington PN. Charlton-Menys V, et al. Clin Chem. 2009 Mar;55(3):473-80. doi: 10.1373/clinchem.2008.111401. Epub 2009 Jan 15. Clin Chem. 2009. PMID: 19147732 Clinical Trial.

3

Small-dense LDL and LDL glycation in metabolic syndrome and in statin-treated and non-statin-treated type 2 diabetes.

Younis NN, Soran H, Sharma R, Charlton-Menys V, Greenstein A, Elseweidy MM, Durrington PN. Younis NN, et al. Diab Vasc Dis Res. 2010 Oct;7(4):289-95. doi: 10.1177/1479164110383063. Epub 2010 Sep 27. Diab Vasc Dis Res. 2010. PMID: 20876207 Free article.

4

Small dense LDL is more susceptible to glycation than more buoyant LDL in Type 2 diabetes.

Younis NN, Soran H, Pemberton P, Charlton-Menys V, Elseweidy MM, Durrington PN. Younis NN, et al. Among authors: charlton menys v. Clin Sci (Lond). 2013 Mar;124(5):343-9. doi: 10.1042/CS20120304. Clin Sci (Lond). 2013. PMID: 22985435

5

Familial hypercholesterolaemia commonly presents with Achilles tenosynovitis.

Beeharry D, Coupe B, Benbow EW, Morgan J, Kwok S, Charlton-Menys V, France M, Durrington PN. Beeharry D, et al. Ann Rheum Dis. 2006 Mar;65(3):312-5. doi: 10.1136/ard.2005.040766. Epub 2005 Sep 21. Ann Rheum Dis. 2006. PMID: 16176995 Free PMC article.

6

Apolipoproteins AI and B as therapeutic targets.

Charlton-Menys V, Durrington P. Charlton-Menys V, et al. J Intern Med. 2006 May;259(5):462-72. doi: 10.1111/j.1365-2796.2006.01646.x. J Intern Med. 2006. PMID: 16629852 Free article. Review.

7

Human cholesterol metabolism and therapeutic molecules.

Charlton-Menys V, Durrington PN. Charlton-Menys V, et al. Exp Physiol. 2008 Jan;93(1):27-42. doi: 10.1113/expphysiol.2007.035147. Exp Physiol. 2008. PMID: 18165431 Free article. Review.

8

Apolipoproteins, cardiovascular risk and statin response in type 2 diabetes: the Collaborative Atorvastatin Diabetes Study (CARDS).

Charlton-Menys V, Betteridge DJ, Colhoun H, Fuller J, France M, Hitman GA, Livingstone SJ, Neil HA, Newman CB, Szarek M, DeMicco DA, Durrington PN. Charlton-Menys V, et al. Diabetologia. 2009 Feb;52(2):218-25. doi: 10.1007/s00125-008-1176-8. Epub 2008 Oct 30. Diabetologia. 2009. PMID: 18972097 Clinical Trial.

9

Apolipoprotein A5 and hypertriglyceridemia.

Charlton-Menys V, Durrington PN. Charlton-Menys V, et al. Clin Chem. 2005 Feb;51(2):295-7. doi: 10.1373/clinchem.2004.044826. Clin Chem. 2005. PMID: 15681559 Free article. No abstract available.

10

Semiautomated method for determination of serum paraoxonase activity using paraoxon as substrate.

Charlton-Menys V, Liu Y, Durrington PN. Charlton-Menys V, et al. Clin Chem. 2006 Mar;52(3):453-7. doi: 10.1373/clinchem.2005.063412. Epub 2006 Jan 19. Clin Chem. 2006. PMID: 16423902

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

40 results

Search Page

Filters